En Es
Categories

Kaya17

KAYA17 is a point-of-care testing developer that has developed a solution for the quick and timely diagnosis of the SARS-CoV-2 virus and is also developing rapid anti-body tests for COVID-19 which can evaluate immunity levels in person’s who have received a vaccination. Additionally, rapid tests for other medical condition ...
Silver member
Products Covid-19Summary
Close

Covid-19 Kaya17

Clinical Laboratory

Point-of-Care Coronavirus Antigen Test
New Antigen Test (NAT)

Kaya17’s New Antigen Test (NAT) for point-of-care SARS-CoV-2 testing gives 98% accurate results with PCR-level sensitivity in 15 minutes, using saliva at less than half the cost of PCR with a free USB-powered reader. The reader processes 30-60 samples/hour and the product has CE-IVD certification.
More details

COVID-19 Immunoassay Kit
KAYA17 COVID Assay Kit

KAYA17 provides a complete immunoassay test kit that contains all disposables and reagents and controls needed, in packs of 25 or 50 tests. Its proprietary reagents are fine-tuned for ease of use by staff with minimal training while maintaining high sensitivity and specificity.
More details

Patient Registration Software
KAYA17's Patient ID Software

KAYA17 has designed a patient registration software that gathers patient information and generates a unique patient QR code that is applied to their sample tube and cartridge used to process their COVID-19 test sample. The software can also receive this information from a QR code from a patient portal app.
More details

Vertical Flow Cartridge (VFC)
KAYA17's Cartridge System

KAYA17 has designed a proprietary one-time use Vertical Flow Cartridge (VFC) on which the COVID-19 test sample is processed, keeping the reader free during this time. The cartridge is inserted into an electronic reader for one minute. The patient ID QR code label is placed on the cartridge to ensure that the sample can be traced at all times.
More details

Results Manager
KAYA17's Results Manager

KAYA17’s system allows parallel COVID-19 testing with multiple readers. One patient ID computer can be connected to 10 readers operating in parallel. The results from all of the readers are transmitted to the patient ID computer where a report is generated for each patient. Results of the test can be printed as a patient test report, sent to their phone, or synched up with a central hospital or healthcare database.
More details

Patient Portal App
KAYA17's Patient Results Portal

The KAYA17 patient portal app has two functions. It helps make patient registration fast, seamless and contactless. Patients can enter their profile information before coming for a COVID-19 test. The second function of the app is to display the results of a test. After the test is completed, the patient does not have to wait for their results at the test site. Results will be automatically sent to their phone. The patient portal app is available in both iOS and android platforms.
More details

Immunoassay Reader
VEGA-200 Reader

KAYA17 has designed a high sensitivity reader to allow its VFF cartridges to be read with high accuracy and speed. The reader is integrated with the company's proprietary software which is embedded in the supplied laptop. The reader is compact, low cost, and runs off USB power.
More details

Critical Care

Point-of-Care Coronavirus Antigen Test
New Antigen Test (NAT)

Kaya17’s New Antigen Test (NAT) for point-of-care SARS-CoV-2 testing gives 98% accurate results with PCR-level sensitivity in 15 minutes, using saliva at less than half the cost of PCR with a free USB-powered reader. The reader processes 30-60 samples/hour and the product has CE-IVD certification.
More details
Close

About Kaya17

KAYA17 is a point-of-care testing developer that has developed a solution for the quick and timely diagnosis of the SARS-CoV-2 virus and is also developing rapid anti-body tests for COVID-19 which can evaluate immunity levels in person’s who have received a vaccination. Additionally, rapid tests for other medical conditions such as tests for allergens, certain cancers, infectious diseases such as dengue fever, and other mutations of the SARS virus, will be created by KAYA17.
FaceBook Twitter Google+ Linked in
Point-of-Care Coronavirus Antigen Test

Point-of-Care Coronavirus Antigen Test

Model: New Antigen Test (NAT)
Request Information

Description:

Kaya17’s New Antigen Test (NAT) for point-of-care SARS-CoV-2 testing gives 98% accurate results with PCR-level sensitivity in 15 minutes, using saliva at less than half the cost of PCR with a free USB-powered reader. The reader processes 30-60 samples/hour and the product has CE-IVD certification.


Send A Message To This Supplier

* Required Information
* Email
To
Kaya17 (Point-of-Care Coronavirus Antigen Test)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions